APA (7th ed.) Citation

United States. Congress. Senate. Committee on Health, Education, Labor, and Pensions, & ProQuest (Firm). (2005). FDA's drug approval process: Up to the challenge? : hearing of the Committee on Health, Education, Labor, and Pensions, United States Senate, One Hundred Ninth Congress, first session, on examining Food and Drug Administration's (FDA) drug approval process, focusing on FDA's drug approval process after a sponsor demonstrates that their benefits outweigh their risks for a specific population and use, and that the drug meet [as printed] meets standards for safety and efficacy, March 1, 2005. U.S. G.P.O..

Chicago Style (17th ed.) Citation

United States. Congress. Senate. Committee on Health, Education, Labor, and Pensions, and ProQuest (Firm). FDA's Drug Approval Process: Up to the Challenge? : Hearing of the Committee on Health, Education, Labor, and Pensions, United States Senate, One Hundred Ninth Congress, First Session, on Examining Food and Drug Administration's (FDA) Drug Approval Process, Focusing on FDA's Drug Approval Process After a Sponsor Demonstrates That Their Benefits Outweigh Their Risks for a Specific Population and Use, and That the Drug Meet [as Printed] Meets Standards for Safety and Efficacy, March 1, 2005. Washington: U.S. G.P.O., 2005.

MLA (9th ed.) Citation

United States. Congress. Senate. Committee on Health, Education, Labor, and Pensions, and ProQuest (Firm). FDA's Drug Approval Process: Up to the Challenge? : Hearing of the Committee on Health, Education, Labor, and Pensions, United States Senate, One Hundred Ninth Congress, First Session, on Examining Food and Drug Administration's (FDA) Drug Approval Process, Focusing on FDA's Drug Approval Process After a Sponsor Demonstrates That Their Benefits Outweigh Their Risks for a Specific Population and Use, and That the Drug Meet [as Printed] Meets Standards for Safety and Efficacy, March 1, 2005. U.S. G.P.O., 2005.